Home › Immune System and Disorders › Kentucky
Immune System and Disorders clinical trials in Kentucky
4 studies for Immune System and Disorders are looking for participants at sites in Kentucky.
Cities in Kentucky
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- University Of Louisville Brown Cancer Center, Louisville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT06722235A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- University Of Louisville Brown Cancer Center, Louisville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06948318Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- University of Louisville Brown Cancer Center, Louisville
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT05826535A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- University of Kentucky Markey Cancer Center, Lexington
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Dec 15, 2025 · NCT06619561From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.